Abstract:Air pollutants are increasingly emitted into the atmosphere because of the high dependency of humans on fossil-derived fuels. Wind speed and direction assisted high dispersibility and uncontrolled nature of air pollution across geo-/demographical borders, making it one of the major global concerns. Besides climate change, air pollution has been found to be associated with various diseases, such as cancer. Lung cancer, which is the world's most common type of cancer, has been found to be associated with traffic-related air pollution. Research and political efforts have been taken to explore green/renewable energy sources. However, these efforts at the current intensity cannot cope with the increasing need for fossil fuels. More specifically, political tensions such as the Russian-Ukraine war, economic tension (e.g., China-USA economic tensions), and other issues (e.g., pandemic, higher inflation rate, and poverty) significantly hindered phasing out fossil fuels. In this context, an increasing global population will be exposed to traffic-related air pollution, which justifies the current uptrend in the number of lung cancer patients. To combat this health burden, novel treatments with higher efficiency and specificity must be designed. One of the potential "life changer" options is microRNA (miRNA)-based therapy to target the expression of oncogenic genes. That said, this review discusses the association of traffic-related air pollution with lung cancer, the changes in indigenous miRNAs in the body during lung cancer, and the current status of miRNA therapeutics for lung cancer treatment. We believe that the article will significantly appeal to a broad readership of oncologists, environmentalists, and those who work in the field of (bio)energy. It may also gain the policymakers' attention to establish better health policies and regulations about air pollution, for example, by promoting (bio)fuel exploration, production, and consumption.

Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer

MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

MicroRNA-targeted therapeutics for lung cancer treatment

Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer

MicroRNAs As Potential Biomarkers in Cancer: Opportunities and Challenges

MicroRNAs modulation in lung cancer: exploring dual mechanisms and clinical prospects

The Potential Clinical Applications and Prospects of Micrornas in Lung Cancer.

Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review

MiRNA-based therapeutic strategy in lung cancer.

Roles of Microrna in Diagnosis, Therapy and Prognosis of Lung Cancer

MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer

Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer

Advances of Microrna in Lung Cancer

Unveiling Prognostic and Diagnostic Power and Their Driving Role in Lung Cancer Progression

Involvement of Micrornas in Lung Cancer Biology and Therapy

Research progress on the relationship between lung cancer drug-resistance and microRNAs

Identification of potential regulatory mechanisms and therapeutic targets for lung cancer

MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment.

MicroRNAs in non‐small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential

Micro-RNAs and lung cancer: A focus on signaling pathways and therapeutics

The Human Microbiome: A Promising Target for Lung Cancer Treatment